Profile data is unavailable for this security.
About the company
Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company focused on developing, advancing, and promoting differentiated products. The Company is engaged in the sale and marketing of several commercial products in ophthalmology and transplant. Its pipeline products include Evolve Intensive Gel, Evolve Daily Intensive, SCOPE Portfolio, Zimed PF and REV-0100 / ReVision. Evolve Intensive Gel and Evolve Daily Intensive contains lubricating eye drops intended for use in the relief of discomfort that arises from dry eye sensations, including dryness, soreness, feelings of grit, and irritation. Zimed PF is a preservative-free multi-dose Bimatoprost for glaucoma patients in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. It plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license.
- Revenue in CAD (TTM)278.21k
- Net income in CAD-2.86m
- Incorporated2013
- Employees12.00
- LocationAequus Pharmaceuticals IncSuite 2820, 200 Granville StreetVANCOUVER V6C 1S4CanadaCAN
- Phone+1 (604) 336-7906
- Fax+1 (604) 336-7906
- Websitehttps://www.aequuspharma.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hill Inc | 2.22m | -1.97m | 1.02m | -- | -- | 1.44 | -- | 0.4587 | -0.6076 | -0.6076 | 0.6822 | 0.2159 | 0.5046 | 129.23 | 4.56 | -- | -44.92 | -77.46 | -48.92 | -101.03 | 68.14 | 50.14 | -89.01 | -153.93 | 2.97 | -4.23 | 0.7881 | -- | -10.23 | 33.86 | 18.26 | -- | 16.21 | -- |
Vitality Products Inc | 789.03k | -193.76k | 1.04m | -- | -- | -- | -- | 1.31 | -0.0047 | -0.0047 | 0.019 | -0.0334 | 0.8649 | 1.14 | 6.42 | -- | -21.24 | -28.04 | -- | -- | 72.26 | 73.72 | -24.56 | -42.49 | 0.1719 | -- | -- | -- | -4.76 | 8.31 | 49.92 | -- | -0.619 | -- |
Genix Pharmaceuticals Corp | 3.98k | -4.00m | 1.78m | -- | -- | -- | -- | 446.41 | -0.0675 | -0.0675 | 0.00007 | -0.023 | 0.002 | 0.0104 | 0.444 | -- | -196.19 | -54.69 | -661.13 | -68.59 | 57.79 | -- | -100,442.00 | -5,345.88 | 0.0412 | -3.29 | -- | -- | -- | -50.60 | -309.27 | -- | -- | -- |
Aequus Pharmaceuticals Inc | 278.21k | -2.86m | 1.99m | 12.00 | -- | -- | -- | 7.15 | -0.0216 | -0.0216 | 0.0021 | -0.0423 | 0.2937 | 1.34 | 4.26 | -- | -302.43 | -97.96 | -- | -293.31 | 53.31 | -- | -1,029.67 | -141.53 | 0.0431 | -13.68 | 10.65 | -- | -81.53 | -28.97 | 7.64 | -- | -- | -- |
Intellipharmaceutics International Inc | 1.23m | -4.31m | 2.65m | 33.00 | -- | -- | -- | 2.16 | -0.1301 | -0.1301 | 0.0371 | -0.528 | 0.6027 | -- | 3.37 | -- | -211.39 | -132.15 | -- | -- | -88.96 | -- | -350.72 | -499.37 | -- | -19.36 | -- | -- | -- | -58.75 | 43.78 | -- | -- | -- |
Radient Technologies Inc | 3.15m | -11.30m | 2.68m | 33.00 | -- | -- | -- | 0.8498 | -0.0216 | -0.0216 | 0.006 | -0.0278 | 0.1108 | 1.56 | 6.00 | -- | -39.76 | -67.36 | -- | -118.27 | -3.91 | 1.66 | -359.00 | -534.11 | 0.0251 | -3.58 | -- | -- | 45.49 | 65.30 | 69.41 | -- | 200.33 | -- |
Manitex Capital Inc. | 0.00 | 676.04k | 2.83m | -- | 4.22 | 0.335 | 5.13 | -- | 0.0534 | 0.0534 | 0.00 | 0.6716 | 0.00 | -- | -- | -- | 7.45 | -10.84 | 8.10 | -11.51 | -- | -- | -- | -- | -- | -- | 0.0392 | -- | -- | -- | 103.54 | 17.10 | -- | -- |